Physician profile
John B Cazale
NPI 1730180449
$511.88
in general payments reported to CMS, 2019-2025
15 companies · $70.39 in 2025
The $70.39 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $90.24 · 2020: $58.83 · 2021: $67.98 · 2022: $189 · 2023: $18.00 · 2024: $17.67 · 2025: $70.39.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $106.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $106.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Becton, Dickinson and Company | $116.31 | 2022 | |
| Depuy Synthes Sales INC. | $110.60 | 2019-2021 | |
| Ferring Pharmaceuticals INC. | $48.51 | 2021-2023 | Euflexxa |
| Abbott Laboratories | $30.31 | 2019-2022 | |
| Boston Scientific Corporation | $28.24 | 2025 | Wavewriter Alpha Prime 16 |
| Sanofi-Aventis U.S. LLC | $28.20 | 2019-2020 | |
| Bioventus LLC | $27.65 | 2025 | Xcell |
| Pacira Pharmaceuticals Incorporated | $26.85 | 2021 | |
| Innovation Technologies INC | $17.67 | 2024 | Irrisept |
| Vertex Pharmaceuticals Incorporated | $14.50 | 2025 | |
| Fidia Pharma USA INC. | $13.63 | 2022 | |
| Medtronic, INC. | $13.52 | 2022 | |
| Abbvie INC. | $12.71 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $12.39 | 2022 | |
| Avanos Medical | $10.79 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Cazale listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.